Skip to main content

Table 2 Example Evaluation Indicators for Participant Enrollment, Follow-Up, Safety and Biological Samples, NIDI Study, 2013ā€“2015

From: Using a monitoring and evaluation framework to improve study efficiency and quality during a prospective cohort study in infants receiving rotavirus vaccination in El Alto, Bolivia: the Infant Nutrition, Inflammation, and Diarrheal Illness (NIDI) study

Study Area

Indicator

Data Source for Indicator

Results

Enrollment

All eligible M-I pairs at each hospital are screened

Clinical records review

2331 charts screened; 2203 age-eligible infants identified

Enrollment of 422Ā M-I pairs in 3Ā months (3ā€“4 pairs/day/hospital)

Enrollment data (weekly monitoring throughout study)

Enrollment of 456Ā M-I pairs in 9Ā months

100% of M-I pairs have properly documented consent forms

Paper copies of consent forms

Successful consent collection from 100% of pairs

Follow-up

10% LTFU (8ā€“9 pairs lost/visit, 380 pairs complete study)

Enrollment data (weekly monitoring throughout study)

15% LTFU (364 infants completed study)

Safety

0 adverse events and 0 study-related severe adverse events

Documentation and follow up of all adverse events (with standard form)

4 adverse eventsa; 5 severe adverse events, 0 study-related severe adverse events

Infant and maternal death rates below DHS rates for Bolivia

Documentation and follow up of all deaths

Among infants enrolled in the NIDI study, there were 0 maternal deaths and 5 infant deaths, equivalent to 10.8 per 1000, less than half of Boliviaā€™s infant mortality rateb.

Monthly reporting of AE/SAE, details of any deaths, reasons for all withdrawals

Documentation of AE/SAE, deaths and reasons for withdrawal using standard forms

100% of withdrawals, deaths, AE/SAE documented

Biological Samples

Successful collection of both infant blood samples from 82% of M-I pairs

Documentation of blood sample collection through survey and laboratory data

Successful collection of first two infant blood samples from 327 infants (75%)

Successful collection of shedding stool samples from 50% of infants

Documentation of stool collection through survey and laboratory data

Successful collection of shedding stool samples from 75% of infants

Successful collection of 25% of diarrhea samples (50% loss to non-reporting, collect 50% reported samples)

Documentation of stool collection through survey and laboratory data

Comparison to Bolivia DHS data

Successful collection of 61% samples of reported diarrhea cases.

  1. aAdverse events included minor bruising and swelling from blood draws
  2. b In Bolivia, there were 23 infant deaths per 1000 post-neonatal infants; 34.7 maternal deaths per 100,000 live births (DHS, 2008)